©€©   www.alternans.org  

MicroVolt T Wave Alternans (MTWA) Risk Assessment of Malignant Arrhythmias (introduction)

European News Web Page

Editor: D. Marangoni  Updated September 1st, 2010

………………………………………………………………………………………………………………………..............

MTWA at 2010 European Congress of Cardiology

ESC important abstract on Pacing modes

 

Shocking revelations at the HRS…

(that’s why it is better to select the ICD patients)

 

MTWA HRS 2010 – Denver presentations

 

Dr. Wojciech Zareba from the University of Rochester refers to an ongoing NIH-sponsored trial of MTWA in MADIT-II patients.

 

MTWA in risk stratification of CDM patients: can it help to better select candidates for ICD implantation? First experience of a single Belgian Center (Belgium Congress of Cardiology 2010)

 

Gene Expression Identifies Molecular Mechanism and Therapeutic Target for Arrhythmogenic Cardiac Alternans

(Circ Arrhythm Electrophysiol. 2009;2:686-694.)

 

PREVENT-SCD trial, presented at the American Heart Association Scientific Sessions in Orlando, Florida, reinforce the value of the Microvolt T-wave Alternans test in identifying patients at risk of sudden cardiac death (SCD).

PREVENT-SCA abstract

 

AHA 2009 TWA presentations

 

Risk stratification for sudden cardiac death: Is there a clinical

role for T wave alternans? (EXTRACT Heart Rhythm 2009;6:S56 –S61)

 

Circulation (July 21st) Correspondence

Letter by De Ferrari and Verrier Regarding Article, "Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy"

 

MTWA at the European Congress of Cardiology in Barcelona (August 31- Sept 1st)

 

Last issues:

 

The Efficacy of Microvolt T-Wave Alternans Testing and Other Noninvasive Risk Stratification Methods for Identifying Patients at Risk of Sudden Cardiac Death (EP Digest June 2009)

 

 

US registry points to substantial risk from ICD, pacemaker replacement

 

TWA Presentations at HRS 2009 in Boston

 

Can we alternate between T-wave alternans testing methods?

Heart Rhythm, Vol 6, No 3, March 2009

 

Heart Rhythm Journal: 4 NEW Full papers on MTWA

Special Issue  Supplement Issue: Risk Factors of Sudden Cardiac Death - Volume 6, Issue 3, Supplement (March 2009)

 

Evidence regarding clinical use of microvolt T-wave alternans,
Stefan H. Hohnloser, Takanori Ikeda, Richard J. Cohen (pdf)


Explaining the clinical manifestations of T wave alternans in patients at risk for sudden cardiac death, 13 October 2008
Michael J. Cutler, David S. Rosenbaum
pages S22-S28
Abstract | Full Text | Full-Text PDF (248 KB)

http://www.heartrhythmjournal.com/webfiles/images/transparent.gif

T-wave alternans in risk stratification of patients with nonischemic dilated cardiomyopathy: Can it help to better select candidates for ICD implantation?, 13 October 2008
Gaetano M. De Ferrari, Antonio Sanzo
pages S29-S35
Abstract | Full Text | Full-Text PDF (210 KB)

http://www.heartrhythmjournal.com/webfiles/images/transparent.gif

http://www.heartrhythmjournal.com/webfiles/images/transparent.gif

Strategies for reducing sudden cardiac death: Application of microvolt T-wave alternans testing in clinical practice, 07 January 2009
Michael J. Mirro
pages S45-S48
Abstract | Full Text | Full-Text PDF (71 KB)

Summary of Meta-analysis and other papers

 

NEW :Dr. Buxton (MUSTT Trial P.I.) comments to the 2008 AHA/ACC/HRS Scientific Statement on Noninvasive Risk Stratification (AHA Learning Library) - Summary

Yale University investigated whether anger-induced MTWA was associated with risk of arrhythmic events (Jacc March 2009)

 

February 2009:

 

Podcast posted on the Heart Rhythm Journal’s website:  Dr. Zipes, editor of the journal, interviews Dr. Rosenbaum about T wave alternans – topics include his take on the MASTER trial and how he uses MTWA in clinical practice:  

Click to Listen http://www.heartrhythmjournal.com/webfiles/images/journals/hrthm/Feb09_David_Rosenbaum_Interview.mp3

 

From JACC: ABCD trial — T-wave alternans to improve sudden cardiac death prevention.

 Watch a related CVN video. http://www.cardiosource.com/images/icon_video.gif

ABCD Trial Key Points

ABCD Trial published

Strategies Using T-Wave Alternans to Improve Efficiency of Sudden Cardiac Death Prevention Published (J Am Coll Cardiol 2009;53:471–9)

 

Editorial: Good results only if MTWA stress / pacing protocols and patient preparation are the standard ones

 

POSITIVE MICROVOLT T-WAVE ALTERNANS IS ASSOCIATED WITH ORGANIC HEART DISEASE IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS AND RIGHT VENTRICULAR OUTFLOW TRACT PATTERN. (Italian Journal of Electrophysiology 2008 Vol 11, 4: 39)

 

Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention (Circulation January 6, 2009Full free on line): no significant differences in the degree of ICD mortality reduction benefit across age and medical comorbidity subgroups  but…

….find differences in the relative benefit associated with ICD therapy among patients screening high- and low-risk with MTWA (P=0.02)

 

 

2008

SCD-Heft Substudy review paper published in Circulation Nov 11, Full  free on line

SCD-HeFT Substudy Review Summary

SCD-Heft Substudy and MASTER published…Comments from D. Rosenbaum , P.Chan and T. Chow

NEW : Potentially life-threatening VA (cycle length ≤260 ms) that resulted in appropriate ICD therapy are found to be more than 3 times the number of appropriate standard ICD Theraphy (J Cardiovasc Electrophysiol.  2008).

ICD therapy used again as end point in SCD-Heft Substudy? but if…Dr Epstein AE, Principal Author of ACC/AHA/HRS2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities wrote in JACC October 2008 : “The fact that ICD therapy is not a surrogate for resuscitation from cardiac arrest is not new information (NASPE 93)”

Biventricular pacing does not affect microvolt T-wave alternans in heart failure patients (Heart Rhythm 2008 ): it can be used before CRT implant.

 

 

The need of a better risk stratification: A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008

Evidence-based framework integrating TWA with other risk factors to stratify risk for sudden cardiac arrest (Progress in Cardiovascular Diseases, Vol. 51, No. 2 (September/October), 2008)

AHA/ACC/HRS Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death (Circulation. 2008;118:1497-1518.) : MTWA still the best method after EF

T-wave alternans test's prognostic horizon exceeds two years in analysis (August 1, 2008 issue of the American Journal of Cardiology.)

Review paper from Dr Theodore Chow( PI of Master Study)

Expert Commentary from T Chow paper

 

OTHER PAPERS


* "Indeterminate" Microvolt T-Wave Alternans Tests Predict High Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction

 

 

* NIH Sponsored Study in JACC Extends Predictive Ability of Microvolt T-Wave Alternans; Non-invasive study shown effective in identifying patients both at high and low risk of sudden cardiac death (J Am Coll Cardiol, 2006; 47:456-463)

 

 

For additional information:

Email

 

SEARCH IN MTWA PAPERS

USER PAGE

 

* Review of Key Clinical Literature (pdf)

 

Use of MTWA in Clinical Practice

NEW POWERPOINT PRESENTATION

 

 

Editor Comments on MMA Method

 

ACC/AHA/ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Cardiac Death – Extracted Sections on  T Wave Alternans in Class 2a (Level of Evidence A): All reference papers are based on the Spectral Analytic Method

 

 

         

Additional Info on T Wave Alternans products : http://www.cambridgeheart.com

 

Automatic update on new papers : dmarangoni@tin.it

 

Statistiche